What were the key findings of the PROAK study, and how did its results inform our understanding of tirbanibulin’s impact on patient quality of life?
Featuring Vishal Patel, MD, FAAD, FACMS | Associate Professor of Dermatology George Washington University School of Medicine & Health Sciences Washington, D.C. | Published October 17, 2025
Related Media
Powered by Polaris TM